Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2015-08-03 Regulatory Filings
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Dechra acquire 63.3% shareholding in Genera d.d
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and the date '03 August 2015', indicating it is a regulatory announcement disseminated via the London Stock Exchange's Regulatory News Service (RNS). The content details a significant corporate action: Dechra Pharmaceuticals PLC's agreement to acquire a controlling stake in Genera d.d. and the subsequent mandatory takeover offer for the remaining shares. This is a material event announcement concerning M&A activity and financing/capital structure implications (mandatory offer). Since the document is an official announcement of a transaction and not a full annual report (10-K), an interim report (IR), or a formal proxy statement (DEF 14A), it fits best under the category describing major corporate transactions or general regulatory news. Given the specific nature of the announcement (acquisition/takeover bid), 'M&A Activity' (TAR) is highly relevant. However, the document is explicitly distributed via RNS and contains the standard RNS footer ('This information is provided by RNS'). In cases where a specific category like TAR exists, it should be prioritized over the general RNS fallback, as this is clearly a takeover announcement. The core subject is the 'Dechra to acquire 63.3% shareholding in Genera d.d.' and the 'Mandatory takeover offer'. Therefore, TAR (M&A Activity) is the most precise classification.
2015-08-03 English
Total Voting Rights
Share Issue/Capital Change Classification · 99% confidence The document is very short (1888 characters) and begins with an 'RNS Number' and the date, indicating it is a regulatory notification service release. The content explicitly states that the company is notifying the market regarding its total issued share capital and the total number of voting rights (87,972,144 shares) for the purpose of Disclosure and Transparency Rules. This type of notification, which reports on share capital changes or total voting rights, fits best under the category of general regulatory announcements or specific share/capital changes. Since it is a notification about the total number of shares for voting purposes, it is closely related to share capital structure. However, the presence of 'RNS Number' and the format strongly suggest a general regulatory filing. Given the options, 'Major Shareholding Notification' (MRQ) deals with changes in *ownership thresholds*, not the total share count itself. 'Share Issue/Capital Change' (SHA) deals with new issues or splits. This specific notification is a mandatory disclosure under DTR 5.6.1R regarding the total denominator for shareholder notifications. While it relates to capital, the primary function here is regulatory disclosure via the RNS system. Since it is a standard, short regulatory update that doesn't fit perfectly into SHA or MRQ, and is explicitly branded as an RNS release, the most appropriate general classification is Regulatory Filings (RNS).
2015-07-31 English
Holding(s) in Company
Director's Dealing Classification · 98% confidence The document is explicitly labeled with "RNS Number : 2656T" and contains a standardized regulatory notification format titled "TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES". This form details changes in significant shareholdings (voting rights crossing a threshold) by a specific entity (Norges Bank). This type of filing, which reports changes in major share ownership, corresponds directly to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2015-07-16 English
Trading Statement & Notice of Results
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number : 4352S' header and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange END'. The content is a 'Trading Update' providing unaudited pre-close highlights for the financial year ended 30 June 2015, stating that preliminary results will be announced later (on 7 September 2015). This structure—a brief update announcing key figures ahead of a formal report—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it provides key financial highlights (revenue growth percentages) but is explicitly a pre-close update rather than the full results, ER is a strong candidate. However, the presence of the RNS identifier and the nature of the announcement (a trading update) often defaults to the general regulatory filing category if a more specific category like ER (which usually accompanies the full results or is the primary release) is not a perfect fit, or if the document is primarily serving as a regulatory notification. Given the document is short (4678 chars) and serves as a regulatory notification of performance highlights before the official results, it fits the definition of an Earnings Release (ER) which is the initial announcement of periodical financial results (key highlights only). If it were just announcing the *release* of the full results, RPA would apply, but here it *contains* the results highlights. Therefore, ER is the most appropriate classification for this pre-close trading update containing key financial metrics.
2015-07-08 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1888 characters) and contains an RNS Number (5661R) and the date of announcement (30 June 2015). The content explicitly states that the company is notifying the market about its total issued share capital and the total number of voting rights (87,971,163 Ordinary Shares) in conformity with DTR 5.6.1R. This type of notification regarding share capital changes or total voting rights is a standard regulatory disclosure. Since it is a direct notification to the market via the RNS service and concerns share structure, it fits best under the general 'Regulatory Filings' category (RNS) or potentially 'Major Shareholding Notification' (MRQ) if it were about a shareholder crossing a threshold, but here it is the company reporting its own total share count. Given the explicit mention of 'RNS Number' and the nature of the disclosure (total shares outstanding), RNS is the most appropriate general regulatory filing code, as it is a direct market notification via the LSE's service.
2015-06-30 English
2015 Special Resolutions
AGM Information Classification · 100% confidence The document is a formal record of resolutions passed at an Annual General Meeting (AGM) of Dechra Pharmaceuticals PLC. It details specific ordinary and special resolutions, such as the authority to allot shares and market purchase authorizations, which are standard business conducted during an AGM. Since it documents the outcomes and specific business transacted at the meeting, it falls under the AGM-R category.
2015-06-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.